Media contacts
 |
Tatyana Albaut PR Director Phone: +7 495 230 02 90 |
Send message:
Shareholders
Pipeline
Media Center
-
Favipiravir in Russia Received Permission for Outpatient Use
24 September 2020
-
Russia’s Chumakov Center Gets Permission for Clinical Trials of its COVID-19 Vaccine
24 September 2020
-
WHO Endorses Protocol for COVID-19 Herbal Medicine Clinical Trials
23 September 2020
-
Coronavir to Become the First COVID-19 Medicine Available in Pharmacies
23 September 2020